Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

2 Views
administrator
administrator
07/18/23

Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next